INS and obesity due to melanocortin 4 receptor deficiency: Furthermore, LCM has demonstrated its ability to inhibit α-glucosidase and α-amylase, reduce postprandial blood glucose levels, and improve insulin sensitivity, thus proving its anti-obesity and glucose-lowering effects [23].